+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

High-grade malignant non-Hodgkin's lymphomas differ from low-grade lymphomas in the extent of apoptosis and their expression of bcl-2, mcl-1, bax and p53



High-grade malignant non-Hodgkin's lymphomas differ from low-grade lymphomas in the extent of apoptosis and their expression of bcl-2, mcl-1, bax and p53



Tumour Biology 19(3): 176-185



In this study, we investigated the extent of apoptosis in 82 non-Hodgkin's lymphoma and 4 reactive follicular hyperplasias and correlated the findings with the extent of apoptosis as determined by the 3'-end labelling method of the apoptotic DNA. To study the influence of apoptosis-regulating proteins bcl-2, bax, mcl-1 and p53 on the extent of apoptosis, we also immunostained the samples with antibodies to them. The results show that there is a significant difference in the extent of apoptosis between low- and high-grade non-Hodgkin's lymphomas, the latter on average showing considerably more apoptotic cells (0.38 +/- 0.30 and 1.44 +/- 1.35%, respectively; p = 0.001). In line with this difference, high-grade lymphomas had significantly more cases with a weak expression of bcl-2 and strong expression of bax (p = 0.00008 and p = 0.016, respectively). They also showed significantly more cases with a positive p53 immunoreactivity (p < 0.00001) and strong mcl-1 immunoreactivity (p = 0.018). The results suggest that apoptosis-affecting genes bcl-2, bax, mcl-1 and p53 all take part in the regulation of apoptosis in malignant non-Hodgkin's lymphomas and contribute to a different level of apoptosis between high- and low-grade non-Hodgkin's lymphomas.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 008774207

Download citation: RISBibTeXText

PMID: 9591044


Related references

High-Grade Malignant Non-Hodgkin’s Lymphomas Differ from Low-Grade Lymphomasin the Extent of Apoptosis andTheir Expression of bcl-2, mcl-1,bax and p53. Tumor Biology 19(3): 176-185, 1998

Gastric high grade b cell lymphomas of malt origin differ in bcl 2 protein expression from nodal high grade b cell lymphomas. Pathology Research & Practice 187(6): 748, 1991

Expression of integrins and CD44 isoforms in non-Hodgkin's lymphomas: CD44 variant isoforms are preferentially expressed in high-grade malignant lymphomas. Journal of Pathology 174(2): 89, 1994

Loss of tumor suppressor gene expression in high-grade but not low-grade non-Hodgkin's lymphomas. American Journal of Clinical Pathology 109(6): 669-674, 1998

The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type. Cancer Research 57(18): 3944-3948, 1997

Low grade malignant non-Hodgkin's lymphomas and peripheral pleomorphic T-cell lymphomas in childhood--a BFM study group report. Klinische Padiatrie 202(4): 258-261, 1990

G csf for treatment intensification in high grade malignant non hodgkin's lymphomas. Onkologie 15(1): 46-48, 50, 1992

Transformation of malignant non-Hodgkin's lymphomas from low- to high-grade malignancy. Annales de Medecine Interne 137(4): 342-345, 1986

Treatment intensification with r-metHuG-CSF in high-grade malignant non-Hodgkin's lymphomas. Onkologie 17(3): 248-253, 1994

Cytogenetic findings in peripheral T-cell lymphomas as a basis for distinguishing low-grade and high-grade lymphomas. Blood 83(2): 505-511, 1994

High-grade transformation of low-grade non-Hodgkin's lymphomas: mechanisms of tumor progression. Leukemia and Lymphoma 34(3-4): 251-259, 1999

Nucleolar ultrastructure in low grade and high grade non hodgkin's lymphomas. Journal of Pathology 163(3): 233-238, 1991

High grade malignant non hodgkin lymphomas nhl initial therapy do details matter. Journal of Cancer Research & Clinical Oncology 116(Suppl. Part 2): 1188, 1990

Computer aided cytometry in high grade malignant non-Hodgkin's lymphomas and tonsils. Virchows Archiv. B Cell Pathology Including Molecular Pathology 58(2): 153-163, 1989

Risk evaluation of therapy strategies in high-grade malignant non-Hodgkin lymphomas. Annals of Hematology 67(Suppl. ): A29, 1993